Ventol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ventol

Property Description
Active ingredient Choline Theophyllinate (Oxtriphylline)
Pharmacological Class Bronchodilator Agents (Xanthine Derivative)
Origin Synthetic derivative
Typical Forms Tablets, Syrup, Nebulization Solutions
General Purpose To improve airflow by relaxing constricted airways

Ventol is a pharmaceutical preparation classified as a Bronchodilator Agent, specifically belonging to the Xanthine derivative group. Its active ingredient is the compound Choline Theophyllinate (INN: Oxtriphylline), a synthetic substance structurally related to natural methylxanthines like Theophylline. The medication is designed to address conditions characterized by constricted airways through a systemic mechanism that focuses on easing muscle tightness. As a systemic agent for obstructive airway diseases, it is categorized under the ATC code R03DA02. This designation reflects the medicine's role in assisting patients with limited breathing capacity.

Understanding the Composition and Purpose of Choline Theophyllinate

The core of Ventol's efficacy lies in its active component, Choline Theophyllinate, which is a highly soluble salt formed by combining the potent bronchodilator Theophylline with Choline. This specific salt formulation is chemically synthesized to enhance solubility and absorption compared to less-soluble forms of Theophylline. Choline Theophyllinate acts through the relaxation of smooth muscle, which serves as a mechanism for opening the bronchial tubes. The primary purpose is to promote the relaxation of the smooth muscles in the bronchial airways, helping to manage persistent tightness and facilitating the maintenance of an open passage for airflow, thereby alleviating the physical feeling of breathlessness.

Available Forms of Ventol

Choline Theophyllinate is available in multiple pharmaceutical preparations, enabling administration via the oral or inhalation route. These include common oral forms such as tablets and sustained-release capsules, as well as liquid oral preparations like syrup. The drug may also be formulated as a solution for nebulization for direct respiratory delivery. The availability of diverse forms ensures the active component can reach the systemic circulation or the respiratory tract efficiently to exert its beneficial bronchodilator effect.

What side effects are possible with Ventol?

Possible Side Effects and Safety Information

The information below is strictly based on adverse reaction data and safety statements found in authoritative regulatory documents, such as FDA Prescribing Information and the EMA Summary of Product Characteristics (SmPC).

Adverse Reactions Classified by Frequency

Adverse reactions are organized by the frequency with which they were observed in clinical trials and post-marketing reports:

Frequency Examples of Documented Reactions
Very Common (≥1/10) Headache, Tremor
Common (≥1/100 to <1/10) Tachycardia (increased heart rate), Palpitations, Throat irritation
Uncommon Muscle cramps
Rare/Very Rare Hypersensitivity reactions, Hypokalemia (low potassium levels)

Serious and Clinically Significant Reactions

Regulatory agencies explicitly document reactions that are rare but serious and require immediate attention, including:

  • Paradoxical Bronchospasm: A sudden, unexpected worsening of breathing difficulty that may be life-threatening and requires immediate discontinuation of the medicine.
  • Immediate Hypersensitivity Reactions: Severe allergic reactions (e.g., angioedema, urticaria, hypotension, and collapse).
  • Cardiovascular Effects: Clinically significant changes in heart rate, blood pressure, or rhythm may occur.

Safety Restrictions and Monitoring Notes

The label defines specific safety constraints and monitoring requirements:

  • Contraindication: Ventol is contraindicated in individuals with a known history of hypersensitivity to the drug or any of its components.
  • Dose Restriction: Patients are warned not to exceed the prescribed dose, as excessive use of inhaled sympathomimetic drugs may be fatal.
  • Metabolic Effects: The potential for a decrease in serum potassium levels (hypokalemia) is documented, which may require monitoring in certain patients.

Population-Specific Safety

  • The safety profile requires caution for use in patients with pre-existing cardiovascular disorders, convulsive disorders, or hyperthyroidism, as the medicine may exacerbate these conditions.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Ventol (Choline Theophyllinate/Oxtriphylline) identifies specific manifestations across several physiological systems. Initial signs often involve gastrointestinal and central nervous system disturbances, including severe and persistent nausea, vomiting (potentially with blood), headache, tremor, and feelings of restlessness.

Overdosage may escalate to life-threatening manifestations such as ventricular arrhythmias and generalized seizures (convulsions). Regulatory authorities mandate that individuals must seek immediate medical attention upon the occurrence of severe symptoms, including any instance of seizures, irregular heartbeat, or unremitting vomiting.

Management of severe toxicity is defined by official procedures focusing on symptomatic and supportive treatment. These procedures include immediate gastrointestinal decontamination using activated charcoal and measures to correct accompanying metabolic disturbances, such as hypokalemia. In cases of severe or life-threatening manifestations, enhanced drug removal procedures, such as hemodialysis, are officially described for implementation in a clinical setting.

Chronic overdosage is noted to carry an increased risk of severe toxicity in vulnerable groups, including the elderly and patients with impaired liver function, often at lower serum concentrations than seen in acute overdose.

Therapeutic Uses of Ventol

Ventol (Choline Theophyllinate) is considered relevant in contexts that involve managing symptoms related to specific respiratory conditions. The medication is utilized in areas where additional support is needed for conditions like Bronchial Asthma and Chronic Obstructive Pulmonary Disease (COPD), including associated issues such as chronic bronchitis and emphysema.

It may be applied in addressing symptom clusters that create noticeable functional strain, such as wheezing, the physical feeling of chest tightness, and pronounced shortness of breath. It is generally relevant in clinical settings where supportive symptom management is appropriate, often applied for managing persistent or recurrent manifestations. This support may assist with maintaining functional stability for daily activities, and may contribute to easing the overall symptom load.


Quick Fact: Relevance for Symptoms of Breathing Distress

Ventol is relevant for easing symptoms related to physical discomfort in conditions characterized by periods of heightened physiological activity and episodic manifestations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ventol (Choline Theophyllinate)

Ventol's eligibility is strictly defined by regulatory documents, identifying specific populations for whom the medicine is prohibited or restricted.

Contraindicated Populations

Ventol is formally contraindicated in patients with known hypersensitivity to Choline Theophyllinate, Oxtriphylline, or any other xanthine derivatives. It must also not be used by individuals with active peptic ulcer disease or certain underlying seizure disorders, as stated in the prescribing information.

Restrictions and Conditional Use

Use is restricted and requires caution in several key populations due to altered drug clearance:

  • Organ Impairment: Patients with impaired liver function (hepatic impairment) or congestive heart failure have significantly reduced drug clearance and require close monitoring.
  • Age Groups: Older adults (ge 60 years) and young children (le 10 years) are at higher risk of toxicity due to changes in drug metabolism.
  • Pregnancy Status: The drug is FDA Pregnancy Category C, meaning use is conditional and only permitted if the potential benefit outweighs the risk. It is also excreted into human milk, requiring careful assessment if used during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ventol (albuterol) is subject to several clinically significant interactions documented in official regulatory labeling, primarily concerning its effects on the cardiovascular system and electrolytes.

Interacting Product Category Official Regulatory Constraint
Beta-Adrenergic Receptor Blocking Agents Generally advised against in asthma patients; can antagonize the bronchodilatory effect of Ventol and may cause severe bronchospasm.
Monoamine Oxidase Inhibitors (MAOIs) Use with extreme caution; may potentiate the effect of Ventol on the vascular system. This caution is extended to use within two weeks of discontinuing MAOI therapy.
Tricyclic Antidepressants (TCAs) Use with extreme caution; may potentiate the effect of Ventol on the vascular system. This caution is extended to use within two weeks of discontinuing TCA therapy.
Non-Potassium-Sparing Diuretics Use with caution; may worsen electrocardiographic changes and/or hypokalemia associated with beta-agonists.
Digoxin Ventol has been shown to decrease serum digoxin levels (16% to 22% reduction in some studies); consider monitoring digoxin levels when co-administered.
Other Adrenergic Drugs Use with caution, regardless of the route of administration, to avoid deleterious cardiovascular effects.

These mandated restrictions define the essential components of the drug's official interaction profile, advising extreme caution with medications that can enhance cardiovascular side effects or antagonize the therapeutic benefit. The constraints on Beta-blockers, MAOIs, and TCAs are the most critical, while co-administration with diuretics and Digoxin requires close monitoring for electrolyte or concentration changes, respectively.

Mechanism of Action

️ How Ventol Works

Ventol's active molecule, Theophylline, exerts its action through multiple, distinct biological targets. The primary mechanism is the non-selective competitive inhibition of Phosphodiesterase (PDE) enzymes (notably isoforms PDE3 and PDE4) within the bronchial smooth muscles. This inhibition prevents the breakdown of the second messengers cyclic AMP (cAMP) and cyclic GMP (cGMP), leading to their accumulation and subsequent reduction in intracellular calcium levels. This molecular cascade directly causes the relaxation of airway smooth muscle, resulting in the widening of the bronchial lumen.

Simultaneously, Theophylline acts as a non-selective competitive antagonist at Adenosine Receptors (A1, A2A, and A2B). By blocking the intrinsic mediator adenosine, the molecule modulates the responsiveness of the airways and, via central action, increases contractility of the primary respiratory muscles. Additionally, the drug modulates gene regulation by enhancing Histone Deacetylase 2 (HDAC2) function, leading to the suppression of pro-inflammatory gene transcription within respiratory cells.

Dosage and Administration Information

Administration Guidelines

Ventol (Choline Theophyllinate, a derivative of Theophylline) is used according to specific administration constraints and a precise dosing methodology. The medication is designated for oral administration, available in forms such as immediate-release liquids or tablets and sustained-release formulations.

The primary difference in use lies in the frequency pattern. Immediate-release forms are typically administered multiple times daily, usually every 6 to 8 hours, while sustained-release tablets are generally taken twice daily (every 12 hours) to achieve consistent blood levels. Regardless of the form, the final dosage is individualized; dose adjustments are guided by Therapeutic Drug Monitoring (TDM), which involves measuring serum drug concentrations to maintain levels within the target range.

Proper intake requires attention to dose integrity. Sustained-release tablets must be swallowed whole and must not be crushed, broken, or chewed, as this action could compromise the controlled release mechanism. These tablets may be taken either with or without food. If a dose is missed, the standard procedure is to skip the forgotten dose and resume the regular schedule, rather than taking a double dose. Furthermore, specific population-based administration rules apply: lower doses are often necessary for older adults and for patients with hepatic impairment.

Recent Clinical Evidence

Research Evidence and Overview of Studies for Ventol (Choline Theophyllinate)

The available research evidence for Ventol is based on clinical evaluations of its active component, Choline Theophyllinate (Oxtriphylline), focusing on conditions for which it has been studied. Studies primarily use designs like Randomized Controlled Trials (RCTs) and Systematic Reviews to explore its use in chronic respiratory conditions. This overview describes what the research has examined and what the evidence suggests, without offering medical advice.


Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

Research has explored the role of the active component of Ventol in adults with stable Chronic Obstructive Pulmonary Disease (COPD). The studies conducted were primarily short-term RCTs and longer-term observational cohort studies. Researchers monitored changes in objective measures, such as lung function tests (e.g., FEV1), and tracked patient-reported outcomes describing episodic changes, such as the frequency of flare-ups or exacerbations. The studies focused on measuring changes in these parameters during the study period.

Studies monitored patterns observed in the research related to short-term changes in lung function measurements. Longer-term evidence derived from observational settings has followed patient groups over extended periods, with some of these studies observing chronic health events. However, long-term effects are not fully established by large-scale, long-duration controlled trials, and comparative evidence is lacking against many other contemporary maintenance treatments.


Evidence for Use as Supportive Therapy in Chronic Asthma

The active component of Ventol was evaluated in research exploring its use as an additional treatment for managing Chronic Asthma. Trials included studies in both adults and children. These studies explored short-term symptom changes, focusing on how frequently patients needed to use quick-relief (rescue) medications, and monitored objective parameters, including airway function measurements.

Studies described the relationship between drug concentration in the blood and measured outcomes, highlighting the need for monitoring during the research process. The research described the compound's use in patients who had an inadequate response to other standard inhaled treatments. Data for certain groups, particularly defining specific concentration levels in the blood in children, remains insufficient; this is a known limitation of the research. Furthermore, the evidence quality varies across studies, and the findings were mixed when trying to define the optimal use of this compound alongside contemporary inhaled treatments for severe asthma.

Key Studies & References Chronic Use of Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Ventol (FAQ)


Q: How quickly can someone expect Ventol to start working?

Official information indicates that Ventol is considered a long-term control medicine, not a quick-relief or 'rescue' treatment. Its active component, theophylline, must reach a steady level in the blood to be effective, which may take some time. The medication is designated to support the maintenance of open airways over time.


Q: What happens if I accidentally take two doses close together?

The official product labeling warns that taking too much of the active component, theophylline, can result in toxicity. High concentrations in the blood may lead to severe symptoms such as persistent vomiting, seizures, or serious changes in heart rhythm (cardiac arrhythmias). Regulatory guidance advises seeking immediate emergency medical services if an overdose is suspected.


Q: What happens when you stop using Ventol?

Regulatory documents and related studies suggest that stopping theophylline therapy suddenly can lead to a significant and rapid worsening of lung function and an increase in respiratory symptoms for some patients. Official guidelines recommend that any changes to the treatment plan be reviewed with a healthcare professional.


Q: Can Ventol be cut in half or crushed?

The official administration guidelines explicitly state that extended-release tablets must be swallowed whole. They must not be broken, crushed, or chewed. This restriction is necessary because altering the tablet form compromises the controlled-release mechanism, potentially leading to a rapid release of the medicine and increasing the risk of toxicity.


Q: Are there any documented interactions between Ventol and alcohol?

Official medical information describes potential issues when alcohol is consumed while taking theophylline. This is because alcohol may worsen side effects like dizziness and could affect underlying disease conditions, particularly in individuals with liver dysfunction.


Q: Can Ventol affect birth control pills?

Official drug interaction information suggests that a person's hormonal status can influence how the body processes theophylline. The metabolism of the active component can be affected by hormonal changes. This indicates that assessment may be required when considering use alongside hormonal contraceptives.


Q: Does taking Ventol require any specific monitoring (like blood tests)?

Yes. Regulatory agencies require Therapeutic Drug Monitoring (TDM). This process involves routine blood tests to measure the concentration of the active component in the patient's serum. Monitoring is necessary to ensure the drug levels are maintained within the defined safe and effective range (10-15 mcg/mL) and to avoid toxicity.


Q: Does Ventol only treat [specific condition]?

The official regulatory documents indicate that the medicine is formally approved for the management and prevention of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD), such as emphysema or chronic bronchitis, and asthma.


Q: How long does the effect of a single dose of Ventol usually last?

The half-life of theophylline, the active component, is generally around eight hours in healthy adults. However, many formulations, especially extended-release tablets, are specifically designed to provide a continuous therapeutic effect for up to 12 or 24 hours to manage chronic symptoms.


Q: Are there any common foods or drinks that should be avoided while using Ventol?

Official regulatory information suggests that patients limit or avoid the intake of caffeine and other related compounds (xanthines), such as those found in certain teas or supplements. These substances may increase certain side effects of theophylline, such as restlessness or a rapid heart rate.


Q: What is the difference between Ventol and a regular vitamin supplement?

According to official classification, Ventol is a prescription medicine categorized as a Bronchodilator Agent (a Xanthine Derivative) used to treat serious respiratory diseases. It is chemically distinct from and is not classified as a vitamin or a general dietary supplement.


Q: Is it normal to feel a bit dizzy when starting Ventol?

Dizziness is a reported side effect of theophylline in regulatory adverse reaction data. This effect can sometimes be a sign that the concentration of the medicine in the blood is slightly too high. It is described that any feelings of dizziness or lightheadedness are to be reviewed by a healthcare provider.


Q: Does Ventol make people feel sleepy or tired?

The active component in Ventol is a central nervous system (CNS) stimulant, meaning its common side effects include increased restlessness and insomnia (difficulty sleeping). Unusual tiredness or sedation is not typically listed as a common reaction but can be documented as a potential symptom of an elevated drug level.


Q: Is Ventol addictive or habit-forming?

Ventol is not classified as a controlled substance by regulatory agencies. While it contains a compound similar to caffeine, which can cause mild dependence, the medicine itself is not generally characterized in official labeling as being addictive or habit-forming.


Q: Is Ventol effective for long-term use?

Ventol is officially classified as a long-term control medicine intended for daily use in managing chronic respiratory conditions. However, regulatory documents mention that while the drug is used chronically, the evidence from large-scale, long-duration controlled trials for long-term effects is limited.


Q: Can using Ventol affect my blood pressure?

Yes, official safety information documents that theophylline can have cardiovascular effects. Specifically, it may increase the heart rate (tachycardia) and, at higher concentrations, has the potential to lead to low blood pressure (hypotension) or other heart rhythm issues.


Q: Is there a generic version of Ventol available?

Official regulatory and pharmaceutical databases confirm that the active component, theophylline, is widely available in generic form from various manufacturers. This availability is consistent with established prescription drug accessibility.


Q: Can Ventol cause changes in mood or behavior?

Yes, official adverse reaction data includes mood and behavioral changes such as irritability, nervousness, restlessness, and anxiety. Due to its stimulating properties, regulatory information describes the need for monitoring these central nervous system-related effects.


Q: Why do some people say Ventol is not effective for them?

Regulatory information notes that theophylline's effectiveness and how the body handles the drug are highly variable among different individuals. This variability in metabolism and clearance is why Therapeutic Drug Monitoring (TDM) may be used to help achieve the desired drug concentration.


Q: Will Ventol interfere with my ability to drive or operate machinery?

Official product information includes warnings that side effects like dizziness or sleeplessness (insomnia) can occur with theophylline use. These central nervous system effects may affect a person's ability to drive safely or operate machinery.


Q: Is it common for people to experience headaches while on Ventol?

Yes, according to official adverse reaction data, headache is listed as a Very Common side effect. This means it has been reported to occur in a significant number of people (ge 1/10) during clinical trials and post-marketing surveillance.


Q: Is Ventol safe for people with diabetes?

Official safety data indicates that theophylline is associated with metabolic effects, including the potential for high blood sugar (hyperglycemia) when high levels are reached. Therefore, patients who have diabetes may require careful monitoring when using this medication.


Q: Can Ventol be taken if I have kidney problems?

While liver function is a primary concern, theophylline is also partially cleared by the kidneys. Regulatory data suggests that renal impairment (kidney problems) can slow the drug's clearance, and is associated with the need for caution and potential dose adjustment.


Q: What is the risk of a serious allergic reaction to Ventol?

Regulatory documents explicitly classify Immediate Hypersensitivity Reactions as a serious and clinically significant safety risk. These severe allergic responses, such as angioedema or sudden collapse, are defined as conditions requiring immediate medical attention.


Q: What should I do if I think Ventol is causing me problems?

Official warnings and precautions state that if a patient experiences persistent or worsening side effects—such as continuous vomiting, severe headache, or a fast or irregular heartbeat—official warnings direct that if these symptoms occur, the medicine is to be stopped and urgent medical attention should be sought.

How should Ventol be stored and disposed of?

How to Store and Dispose of Ventol?

The official storage and disposal requirements for Ventol (Choline Theophyllinate) are defined by government regulatory documents to maintain product integrity and ensure public safety.


Official Storage Conditions

The medication must be stored at room temperature, protected from both excessive heat and freezing, particularly for liquid forms. It is mandatory to keep the product in its original container with the lid tightly closed, securing it away from light and moisture to prevent degradation. All forms must be stored out of the sight and reach of children and pets to prevent accidental ingestion.

Disposal Requirements

To discard expired or unused Ventol, follow regulatory instructions by using a drug take-back program or collection receptacle. If these are unavailable, the alternative is to remove the drug from its container, mix it with an undesirable substance (like coffee grounds or dirt), place the mixture in a sealed bag, and discard it in household trash. Do not flush this medicine down the toilet or pour it down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ventol found in:

A-Z Index: